Venrock Healthcare Capital Partners III, L.P.

Holdings History for Spyre Therapeutics, Inc. - Common Stock, par value $0.0001 per share (SYRE)

Symbol: SYRE on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 2.69M shares
Security Ownership: 4.6%

Venrock Healthcare Capital Partners III, L.P. ownership in Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share (SYRE)

2025-02-14 - Venrock Healthcare Capital Partners III, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.69M shares of Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share (SYRE). This represents 4.6% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Venrock Healthcare Capital Partners III, L.P.	4.6%		$49.8M	2.69M			$18.56	13G/A	12/31/2024	14 Feb 2025 18:06:48